Haller, Sabine; Güsewell, Sabine; Egger, Thomas; Scanferla, Giulia; Thoma, Reto; Leal-Neto, Onicio B; Flury, Domenica; Brucher, Angela; Lemmenmeier, Eva; Möller, J Carsten; Rieder, Philip; Rütti, Markus; Stocker, Reto; Vuichard-Gysin, Danielle; Wiggli, Benedikt; Besold, Ulrike; Kuster, Stefan P; McGeer, Allison; Risch, Lorenz; Schlegel, Matthias; ... (2022). Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort. Antimicrobial resistance and infection control, 11(1), p. 27. BioMed Central 10.1186/s13756-022-01070-6
|
Text
13756_2022_Article_1070.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
BACKGROUND
There is insufficient evidence regarding the role of respirators in the prevention of SARS-CoV-2 infection. We analysed the impact of filtering facepiece class 2 (FFP2) versus surgical masks on the risk of SARS-CoV-2 acquisition among Swiss healthcare workers (HCW).
METHODS
Our prospective multicentre cohort enrolled HCW from June to August 2020. Participants were asked about COVID-19 risk exposures/behaviours, including preferentially worn mask type when caring for COVID-19 patients outside of aerosol-generating procedures. The impact of FFP2 on (1) self-reported SARS-CoV-2-positive nasopharyngeal PCR/rapid antigen tests captured during weekly surveys, and (2) SARS-CoV-2 seroconversion between baseline and January/February 2021 was assessed.
RESULTS
We enrolled 3259 participants from nine healthcare institutions, whereof 716 (22%) preferentially used FFP2. Among these, 81/716 (11%) reported a SARS-CoV-2-positive swab, compared to 352/2543 (14%) surgical mask users; seroconversion was documented in 85/656 (13%) FFP2 and 426/2255 (19%) surgical mask users. Adjusted for baseline characteristics, COVID-19 exposure, and risk behaviour, FFP2 use was non-significantly associated with decreased risk for SARS-CoV-2-positive swab (adjusted hazard ratio [aHR] 0.8, 95% CI 0.6-1.0) and seroconversion (adjusted odds ratio [aOR] 0.7, 95% CI 0.5-1.0); household exposure was the strongest risk factor (aHR 10.1, 95% CI 7.5-13.5; aOR 5.0, 95% CI 3.9-6.5). In subgroup analysis, FFP2 use was clearly protective among those with frequent (> 20 patients) COVID-19 exposure (aHR 0.7 for positive swab, 95% CI 0.5-0.8; aOR 0.6 for seroconversion, 95% CI 0.4-1.0).
CONCLUSIONS
Respirators compared to surgical masks may convey additional protection from SARS-CoV-2 for HCW with frequent exposure to COVID-19 patients.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Risch, Lorenz |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2047-2994 |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Karin Balmer |
Date Deposited: |
23 Nov 2022 07:22 |
Last Modified: |
05 Dec 2022 16:28 |
Publisher DOI: |
10.1186/s13756-022-01070-6 |
PubMed ID: |
35123572 |
Uncontrolled Keywords: |
Aerosol COVID-19 Healthcare workers Respirator Surgical mask |
BORIS DOI: |
10.48350/175025 |
URI: |
https://boris.unibe.ch/id/eprint/175025 |